ARCHIVES

A Low-Cost Vaccine To Enter Clinical Trials In A Year

This article is from The Cancer Letter archive.

Vol. 33 No. 9 | September 24, 2010

Download PDF Visit The Full Archive

Related Articles

DCBD Board Okays Recombinant DNA Diagnosis Concept, Two Others, But Rejects Three

June 3, 1983

Under A Flat Budget, NIH Suspends Grant Increases, May restore Funds Later.

November 24, 2000

Responses So Far Support Outstanding Investigator Grant; NCAB Members Object To Salary commitment

July 8, 1983

Budget Year

November 12, 2010

FDA Approves Femara As First-Line Treatment For Advanced Breast Cancer.

January 26, 2001

Young Investigators Hold Their Own

September 28, 1979